每小时滴定与每2小时固定剂量口服米索前列醇溶液引产的随机临床试验
本随机对照试验比较每小时滴定剂量与每2小时固定剂量口服米索前列醇溶液引产的有效性和安全性。2013年12月至2015年7月共146名妇女随机分组,24小时内阴道分娩率分别为64.4%和65.8%(P=1.00),无显著差异;每小时滴定组发热和胎粪污染羊水更常见。结论认为每2小时固定剂量方案疗效相似且副作用和并发症更少。
要点
- 每小时滴定剂量与每2小时固定剂量口服米索前列醇溶液的24小时内阴道分娩率无显著差异。
- 每小时滴定组发热和胎粪污染羊水发生更频繁。
- 每2小时固定剂量方案疗效相似且副作用和并发症更少。
核心结论
- 每2小时固定剂量口服米索前列醇溶液与每小时滴定剂量方案疗效相似,但副作用和并发症更少。
研究设计与样本
- 随机对照研究,计划样本量146名妇女,实际从2013年12月至2015年7月随机分配146名妇女。
- 每小时滴定组:20 μg每小时(≤4剂),无规律宫缩时增至40 μg每小时(≤4剂),再增至60 μg每小时(≤16剂)。
- 每2小时固定剂量组:25 μg每2小时直至活跃产程开始(≤12剂)。
主要发现
- 24小时内阴道分娩:每小时滴定组47例(64.4%) vs 每2小时固定剂量组48例(65.8%)(P=1.00)。
- 初产妇24小时内阴道分娩率两组无显著差异(P=1.00)。
- 过期妊娠24小时内阴道分娩率两组无显著差异(P=.66)。
- Bishop评分≤3分者24小时内阴道分娩率两组无显著差异(P=.84)。
- 缩宫素加强者24小时内阴道分娩率两组无显著差异(P=.83)。
临床怎么用
- 作者认为每2小时固定剂量口服米索前列醇溶液与每小时滴定剂量方案疗效相似,且副作用和并发症更少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Misoprostol is an effective agent for the induction of labor. Existing guidelines recommend oral misoprostol solution 25 μg every 2 hours. However, more research is required to optimize the use of oral misoprostol solution for the induction of labor. OBJECTIVE: The purpose of this study was to compare efficacy and safety of hourly titrated-dose oral misoprostol solution with static-dose oral misoprostol solution every 2 hours for labor induction. STUDY DESIGN: In this randomized controlled study, oral misoprostol solution was administered as (1) 20 μg hourly (≤4 doses) that was increased in the absence of regular uterine contractions to 40 μg hourly (≤4 doses) and then to 60 μg hourly (≤16 doses) or (2) 25 μg every 2 hours until active labor began (≤12 doses). A sample size of 146 women was planned with the use of a projected 95% rate for the primary endpoint (vaginal delivery within 24 hours) for hourly titrated-dose misoprostol and 80% rate for static-dose misoprostol every 2 hours. Safety outcomes included maternal morbidity and adverse neonatal outcomes. RESULTS: From December 2013 to July 2015, 146 women were assigned randomly to treatment. Demographic and clinical factors were similar between groups, except for age. Vaginal delivery was achieved within 24 hours in 47 women (64.4%) who received hourly titrated-doses of misoprostol solution and 48 women (65.8%) who received 2-hourly static-dose misoprostol solution (P=1.00). Rates of vaginal delivery within 24 hours did not differ significantly between treatment groups for women who were nulliparous (P=1.00) or who had postterm pregnancies (P=.66), a Bishop score of ≤3 (P=.84), or oxytocin augmentation (P=.83). Cesarean deliveries were performed within 24 hours in 9 women who received hourly titrated-dose misoprostol solution and 2 women who received 2-hourly static-dose misoprostol solution (P=.056). Pyrexia and meconium-stained liquor occurred more frequently with the hourly titrated-dose regimen. CONCLUSION: The static-dose oral misoprostol solution every 2 hours has similar efficacy as hourly titrated-dose misoprostol solution but with fewer side-effects and lower complication rates.
引用
- Rouzi AA, Alsahly N, Alamoudi R, et al. Randomized clinical trial between hourly titrated and 2 hourly static oral misoprostol solution for induction of labor. Am J Obstet Gynecol. 2016. PMID: 27986461. doi:10.1016/j.ajog.2016.11.1054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。